The global antimicrobial urinary catheters market was valued at USD 1.2 billion in 2025 and is expected to reach USD 2.3 billion by 2033, expanding at a CAGR of 8.5% from 2026 to 2033. The market is estimated to increase from USD 1.3 billion in 2026 to USD 2.3 billion by 2033. North America led the global market in 2025, accounting for 37.7% of revenue.

The primary growth driver is the increasing incidence of catheter-associated urinary tract infections (CAUTIs). Healthcare providers are increasingly adopting antimicrobial urinary catheters to strengthen infection prevention, improve patient safety, and reduce complications in hospitals and home-care environments.

What Is Driving Market Growth?

The increasing prevalence of chronic conditions that require urinary catheterization is supporting demand for antimicrobial catheter technologies. Conditions such as spinal cord injuries, urinary retention, and neurogenic bladder can increase the need for catheter use and, consequently, infection-prevention solutions.

CAUTIs remain a major concern because infections can result in complications, prolonged hospital stays, and higher healthcare costs. As hospitals and long-term care facilities place greater emphasis on reducing healthcare-associated infections, antimicrobial-coated and antibiotic-impregnated catheters are gaining importance.

Regulatory attention toward hospital-acquired infection prevention is also encouraging healthcare facilities to adopt advanced catheter technologies. At the same time, technological improvements, including silver-coated and antibiotic-impregnated catheters, are expanding the available options for infection control.

Market Segmentation Highlights

Several product and technology categories represented leading positions in the market in 2025:

• Product: Intermittent catheters held the largest market share.
• Material: Silicone-based catheters accounted for the largest share.
• Coating: Hydrophilic coatings represented the leading segment.
• Catheterization: Short-term catheterization held the largest market share.
• Gender: Male catheters accounted for the largest share.

Download a free sample report or claim your copy of this full market intelligence report

North America Leads the Global Market

North America was the largest regional market in 2025, generating 37.7% of global revenue. The U.S. held the largest market share by country during the same year.

The region's leading position is supported by the need for effective infection-control measures and the adoption of advanced catheter technologies across healthcare settings. Growing awareness of CAUTI prevention and increasing emphasis on patient outcomes further contribute to regional demand.

CAUTI Burden Reinforces Demand for Antimicrobial Catheters

Data reported through the National Healthcare Safety Network (NHSN) demonstrate the scale of CAUTIs across healthcare facilities. In 2023, 21,525 CAUTIs were reported across 6,452 healthcare facilities. Acute care hospitals accounted for the majority of reported infections, with 17,370 CAUTIs reported across 3,774 facilities.

Source: Association for Professionals in Infection Control and Epidemiology

The reported infection burden highlights the continuing need for effective CAUTI prevention strategies. Hospitals and long-term care facilities are therefore increasingly evaluating advanced catheter technologies designed to reduce infection risk, improve patient outcomes, and limit the economic impact associated with infection-related healthcare costs.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Infection Prevention Programs Support Adoption

Facility-specific CAUTI prevention programs are placing greater emphasis on identifying infection risks and addressing gaps in infection-control practices. Within these multidisciplinary programs, antimicrobial urinary catheters can serve as a targeted intervention where appropriate.

The increasing prevalence of bacterial infections and concerns surrounding antimicrobial resistance are also strengthening the focus on infection prevention. According to the WHO, antimicrobial resistance was associated with 1.27 million deaths in 2019, with projections indicating that deaths could reach 10 million annually by 2050 because of antibiotic overuse and misuse.

These concerns reinforce the importance of technologies that can help reduce infection risk while supporting patient care. Antimicrobial urinary catheters are consequently gaining attention as part of broader infection-prevention strategies.

Advances in Antimicrobial Coating Technology

Innovation in antimicrobial coating technologies is another important market development. Newer catheter surfaces are designed to limit bacterial adhesion and biofilm formation, two factors associated with catheter-related infections.

Technologies including silver alloy coatings, antibiotic-impregnated materials, and antimicrobial polymer surfaces are improving infection-control capabilities while maintaining catheter biocompatibility. Continued advances in these materials and coating technologies are supporting adoption across hospitals, long-term care facilities, and home-care settings.

Antimicrobial Urinary Catheters Market Size & Forecast

• 2025 market size: USD 1.2 billion
• 2026 estimated market size: USD 1.3 billion
• 2033 projected market size: USD 2.3 billion
• CAGR, 2026–2033: 8.5%
• Leading region: North America
• North America revenue share, 2025: 37.7%
• Leading country: U.S.

Overall, the antimicrobial urinary catheters market is positioned for continued growth as healthcare providers focus on CAUTI prevention, infection control, patient safety, and cost reduction. Rising catheterization needs associated with chronic conditions, stronger infection-prevention initiatives, and advances in antimicrobial coating technologies are expected to support market expansion through 2033.

Key Antimicrobial Urinary Catheters Companies

Companies profiled in the study include:

• BD (Bactigaurd)
• MEDLINE
• ConvaTec Group PLC
• WellLead Medical Co., Ltd.
• Silq Technologies
• AvantGuard (Halomine Inc.)

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.